Dyslipidemia Prevalence in Iranian Adult Men: The Impact of Population-Based Screening on the Detection of Undiagnosed Patients.
10.5534/wjmh.2015.33.3.167
- Author:
Abolfazl MOHAMMADBEIGI
1
;
Esamil MOSHIRI
;
Narges MOHAMMADSALEHI
;
Hossein ANSARI
;
Ali AHMADI
Author Information
1. Department of Epidemiology and Biostatistics, Health Policy and Promotion Research Center, Qom University of Medical Sciences, Qom, Iran.
- Publication Type:Original Article
- Keywords:
Dyslipidemia;
Hypercholesterolemia;
Hypertriglyceridemia;
Male;
Metabolic diseases
- MeSH:
Adult*;
Cardiovascular Diseases;
Cholesterol;
Dyslipidemias*;
Humans;
Hypercholesterolemia;
Hypertriglyceridemia;
Life Style;
Lipoproteins;
Male;
Mass Screening*;
Metabolic Diseases;
Prevalence*;
Risk Factors;
Secondary Care
- From:The World Journal of Men's Health
2015;33(3):167-173
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Dyslipidemia has been established as one of the most important modifiable risk factors for cardiovascular disease. Due to the higher prevalence of dyslipidemia in males, this study aimed to estimate the prevalence of dyslipidemia in Iranian urban men. MATERIALS AND METHODS: A screening program was conducted in 845 Iranian men 25 years of age and older in 2014. A health interview survey was conducted to evaluate the prevalence of self-reported dyslipidemia and to collect demographic data, as well as serum lipid profile screening by a reference laboratory. Lipoprotein levels was categorized based on the Adult Treatment Panel III criteria and the data were analyzed using the chi-square test and analysis of variance. RESULTS: The overall prevalence of dyslipidemia was 51.8%, and the prevalence of various forms of dyslipidemia was as follows: hypercholesterolemia (> or =240 mg/dL), 11.4%; hyper-low-density lipoprotein cholesterol (> or =160 mg/dL), 9.6%; hypertriglyceridemia (> or =200 mg/dL), 25%; and hypo-high-density lipoprotein (HDL) cholesterol (<40 mg/dL), 34.3%. With the exception of hypo-HDL, all forms of dyslipidemia were significantly less common in men over 65 years of age (p<0.05). CONCLUSIONS: The prevalence of hypo-HDL and hypertriglyceridemia was higher than expected in Iranian adult men, with half of men 25 years of age and older affected by at least one form of dyslipidemia. A large gap in primary and secondary care was observed, because nearly 80% of patients with dyslipidemia were unaware of their status. Urgent preventive programs and lifestyle changes are necessary to reduce the prevalence of cardiovascular risk factors.
